CN101904918B - 克咳片及其制备方法 - Google Patents
克咳片及其制备方法 Download PDFInfo
- Publication number
- CN101904918B CN101904918B CN2010102380702A CN201010238070A CN101904918B CN 101904918 B CN101904918 B CN 101904918B CN 2010102380702 A CN2010102380702 A CN 2010102380702A CN 201010238070 A CN201010238070 A CN 201010238070A CN 101904918 B CN101904918 B CN 101904918B
- Authority
- CN
- China
- Prior art keywords
- cough
- relieving tablets
- powder
- dry granulation
- relieving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010011224 Cough Diseases 0.000 title claims abstract description 76
- 238000002360 preparation method Methods 0.000 title abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 91
- 239000000463 material Substances 0.000 claims abstract description 70
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 52
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 39
- 238000007908 dry granulation Methods 0.000 claims abstract description 35
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 26
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 24
- 229920000881 Modified starch Polymers 0.000 claims abstract description 24
- 239000008101 lactose Substances 0.000 claims abstract description 24
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 23
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 23
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 23
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 23
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 23
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims description 53
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 21
- 239000013618 particulate matter Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 5
- 229940057948 magnesium stearate Drugs 0.000 claims description 5
- 229960001866 silicon dioxide Drugs 0.000 claims description 5
- 239000008187 granular material Substances 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 9
- 244000005700 microbiome Species 0.000 abstract description 4
- 238000009475 tablet pressing Methods 0.000 abstract 3
- 229940057838 polyethylene glycol 4000 Drugs 0.000 abstract 2
- 238000009776 industrial production Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 230000002950 deficient Effects 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000003754 machining Methods 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 238000005550 wet granulation Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000202807 Glycyrrhiza Species 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
样品 | 外观性状 | 崩解时限(min) | 微生物限度 | 硬度(N) | 水分(%) |
实施例1 | 外表光洁 | 14min | 符合规定 | 8.2 | 0.36 |
实施例2 | 外表光洁 | 16min | 符合规定 | 8.4 | 0.38 |
实施例3 | 外表光洁 | 15min | 符合规定 | 8.6 | 0.37 |
对比例1 | 外表光洁 | 32min | 不符合规定 | 19 | 2.36 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102380702A CN101904918B (zh) | 2010-07-27 | 2010-07-27 | 克咳片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102380702A CN101904918B (zh) | 2010-07-27 | 2010-07-27 | 克咳片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101904918A CN101904918A (zh) | 2010-12-08 |
CN101904918B true CN101904918B (zh) | 2012-02-01 |
Family
ID=43260604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102380702A Active CN101904918B (zh) | 2010-07-27 | 2010-07-27 | 克咳片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101904918B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105853375A (zh) * | 2016-05-27 | 2016-08-17 | 南京柯菲平盛辉制药有限公司 | 一种干法制备脑脉利颗粒的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1456214A (zh) * | 2003-01-16 | 2003-11-19 | 毛友昌 | 克咳片的制备方法 |
CN100415209C (zh) * | 2004-12-02 | 2008-09-03 | 贵州益佰制药股份有限公司 | 克咳制剂及其制备方法 |
-
2010
- 2010-07-27 CN CN2010102380702A patent/CN101904918B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101904918A (zh) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101147746A (zh) | 一种中药材破壁粉的加工方法 | |
CN102988993B (zh) | 复方对乙酰氨基酚片主要辅料的筛选和组成及其制备方法 | |
CN103099789A (zh) | 一种维生素c颗粒的制备方法 | |
CN103040774B (zh) | 埃索美拉唑镁肠溶片中埃索美拉唑镁的制粒包衣工艺 | |
CN105147614B (zh) | 一种包含bibw 2992ma2的固体制剂及其制备方法 | |
CN104983732B (zh) | 一种布洛肾素那敏片及其制备方法 | |
CN104306344A (zh) | 一种阿齐沙坦片剂及其制备工艺 | |
CN101904918B (zh) | 克咳片及其制备方法 | |
CN101390840B (zh) | 一种能够直接压片的高含量抗坏血酸钙颗粒的生产方法 | |
CN104840499B (zh) | 一种消癌平片及其制备方法 | |
CN104546476A (zh) | 一种兽用中药颗粒剂干法制粒方法 | |
CN101785796B (zh) | 金感胶囊的制备方法 | |
CN102077955A (zh) | 可溶性魔芋膳食纤维片及其制作方法 | |
CN103330692A (zh) | 提高稳定性的辛伐他汀组分及其制备方法 | |
CN115531327B (zh) | 一种厄贝沙坦片及其制备方法 | |
CN110507621A (zh) | 一种劳拉西泮片的制备方法 | |
CN113318083A (zh) | 一种天然提取物的制剂工艺 | |
CN100566718C (zh) | 复方罗布麻片i中氢氯噻嗪的制粒、包衣工艺 | |
CN1883644A (zh) | 一种治疗妇科疾病的中药片剂及其制备工艺 | |
CN103610713B (zh) | 一种复方岩白菜素片及制备方法 | |
CN105919958A (zh) | 一种来那度胺分散片的制备方法 | |
CN102000338B (zh) | 一种二氧化硅小丸及制备方法 | |
CN104288144A (zh) | 含有维格列汀、盐酸二甲双胍复方制剂的制备方法 | |
CN103315971B (zh) | 阿卡波糖片及其制备方法 | |
CN102600475B (zh) | 一种药用微丸丸芯及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HAINAN GOURD DOLL PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: HAINAN XINZHONGZHENG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Patentee after: HAINAN GOURD DOLL PHARMACEUTICAL Co.,Ltd. Address before: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Patentee before: HAINAN XINZHONGZHENG PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Patentee after: HAINAN HULUWA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 570216, East B District, No. 6, Haikou Free Trade Zone, No. 168 Nanhai Road, Hainan, Haikou Patentee before: HAINAN GOURD DOLL PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Keke tablet and its preparation method Effective date of registration: 20200821 Granted publication date: 20120201 Pledgee: Bank of Communications Ltd. Hainan branch Pledgor: HAINAN HULUWA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2020980005271 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230328 Granted publication date: 20120201 Pledgee: Bank of Communications Ltd. Hainan branch Pledgor: HAINAN HULUWA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2020980005271 |